Skip to main content
Invea Therapeutics, Inc. (INAI)
Invea Therapeutics was planning to go public, but the IPO was withdrawn on Mar 29, 2024.
Stock Price: Pending
IPO price not available yet

Invea Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year
 20222021
Selling, General & Admin
2.261.1
Research & Development
3.452.51
Operating Expenses
5.73.62
Operating Income
-5.7-3.62
Interest Expense / Income
0.05-
Pretax Income
-5.75-3.62
Net Income
-5.75-3.62
Free Cash Flow
-5.26-3.1
EBITDA
-5.7-3.62
Depreciation & Amortization
0-
EBIT
-5.7-3.62
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).